Search hospitals > New Hampshire > Lebanon
Dartmouth-Hitchcock Medical Center
Claim this profileLebanon, New Hampshire 03766
Global Leader in Lung Cancer
Global Leader in Parotid Gland Cancer
Conducts research for Breast Cancer
Conducts research for Cancer
Conducts research for Non-Small Cell Lung Cancer
1082 reported clinical trials
83 medical researchers
Summary
Dartmouth-Hitchcock Medical Center is a medical facility located in Lebanon, New Hampshire. This center is recognized for care of Lung Cancer, Parotid Gland Cancer, Breast Cancer, Cancer, Non-Small Cell Lung Cancer and other specialties. Dartmouth-Hitchcock Medical Center is involved with conducting 1,082 clinical trials across 1,283 conditions. There are 83 research doctors associated with this hospital, such as Julie Kim, Kathryn C. Hourdequin, Konstantin H. Dragnev, and Manik A. Amin.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
2Parotid Gland Cancer
Global LeaderStage IV
Stage III
HER2 positive
Top PIs
Julie KimDartmouth Hitchcock Medical Center8 years of reported clinical research
Expert in Cancer
Studies Adult T-Cell Leukemia/Lymphoma
26 reported clinical trials
72 drugs studied
Kathryn C. HourdequinDartmouth Hitchcock Medical Center/Dartmouth Cancer Center8 years of reported clinical research
Studies Pancreatic Cancer
Studies Parotid Gland Cancer
19 reported clinical trials
35 drugs studied
Konstantin H. DragnevDartmouth Hitchcock Medical Center6 years of reported clinical research
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
16 reported clinical trials
49 drugs studied
Manik A. AminWashington University School of Medicine6 years of reported clinical research
Studies Cervical Adenocarcinoma
Studies Pancreatic Cancer
12 reported clinical trials
26 drugs studied
Clinical Trials running at Dartmouth-Hitchcock Medical Center
Lung Cancer
Multiple Myeloma
Breast Cancer
Cancer
Small Cell Lung Cancer
Brain Tumor
Non-Small Cell Lung Cancer
Plasma Cell Neoplasm
Liver Cancer
Fuchs' Dystrophy
Serplulimab + Chemotherapy
for Small Cell Lung Cancer
This trial is testing two different treatment combinations for patients with extensive-stage small cell lung cancer who have not received any prior treatment. One group will receive a new drug called Serplulimab along with standard chemotherapy, while the other group will receive an existing drug called Atezolizumab with the same chemotherapy. Both immunotherapy drugs aim to help the immune system fight cancer, and the chemotherapy drugs work by killing cancer cells. Atezolizumab has been shown to improve survival in small-cell lung cancer when combined with chemotherapy, changing the standard first-line therapy.
Recruiting3 awards Phase 32 criteria
Dato-DXd + Pembrolizumab
for Advanced Lung Cancer
This study is designed to assess the efficacy and safety of datopotamab deruxtecan (Dato-DXd) in combination with pembrolizumab versus pembrolizumab alone in participants with advanced or metastatic non-small cell lung cancer (NSCLC) of non-squamous histology.
Recruiting2 awards Phase 313 criteria
Ifinatamab Deruxtecan
for Small Cell Lung Cancer
This study was designed to compare the efficacy and safety of I-DXd with treatment of physician's choice in participants with relapsed small cell lung cancer (SCLC).
Recruiting2 awards Phase 36 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Dartmouth-Hitchcock Medical Center?
Where is Dartmouth-Hitchcock Medical Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does Dartmouth-Hitchcock Medical Center accept?
What awards or recognition has Dartmouth-Hitchcock Medical Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.